Danaher Says China VBP Impact Now ‘Modest and Manageable’ As Diagnostic Headwinds Ease
Danaher CEO Blair says most manufacturing of diagnostics equipment and reagents for sale in China will be localized by year-end.
Blair shed some light on the company’s fourth-quarter diagnostics expectations, excluding China and respiratory testing. 
